Z\u0101\u013cu valsts a\u0123ent\u016bra inform\u0113, ka Eiropas Z\u0101\u013cu a\u0123ent\u016bras (EZA) Z\u0101\u013cu re\u0123istr\u0101cijas komiteja (CHMP) ir ieteikusi re\u0123istr\u0113t divas vakc\u012bnas, kas ir piel\u0101gotas, lai nodro\u0161in\u0101tu pla\u0161\u0101ku aizsardz\u012bbu pret Covid-19.<\/p>\n\n\n\n
Piel\u0101got\u0101s vakc\u012bnas \u201cComirnaty Original\/Omicron BA.1\u201d un \u201cSpikevax Bivalent Original\/Omicron BA.1\u201d ir paredz\u0113tas lieto\u0161anai person\u0101m no 12 gadu vecuma, kuras sa\u0146\u0113mu\u0161as vismaz prim\u0101ro vakcin\u0101ciju pret Covid-19. \u0160\u012bs piel\u0101got\u0101s vakc\u012bnas ir ori\u0123in\u0101lo vakc\u012bnu \u201cComirnaty\u201d (Pfizer\/BioNTech) un \u201cSpikevax\u201d (Moderna) izmain\u012btas versijas, kas paredz\u0113tas aizsardz\u012bbai gan pret omikrona apak\u0161paveidu BA.1, gan pret ori\u0123in\u0101lo SARS-CoV-2 v\u012brusu. <\/p>\n\n\n\n
Vakc\u012bnas ir piel\u0101gotas, lai lab\u0101k atbilstu cirkul\u0113jo\u0161ajiem SARS-CoV-2 paveidiem. Piel\u0101got\u0101s vakc\u012bnas var papla\u0161in\u0101t aizsardz\u012bbu pret da\u017e\u0101diem paveidiem, un t\u0101p\u0113c sagaid\u0101ms, ka t\u0101s nodro\u0161in\u0101s optim\u0101lu aizsardz\u012bbu pret Covid-19 laik\u0101, kad v\u012bruss att\u012bst\u0101s un p\u0101rveidojas. <\/p>\n\n\n\n
Imuniz\u0101cijas valsts padomes<\/strong> (IVP)<\/strong> rekomend\u0101cija <\/strong><\/p>\n\n\n\n Saska\u0146\u0101 ar IVP rekomend\u0101ciju Covid-19 rudens sezonai [saite uz https:\/\/www.vm.gov.lv\/lv\/media\/10346\/download<\/a>], sezon\u0101la vakcin\u0101cija pret Covid-19 rekomend\u0113jama visai sabiedr\u012bbai. Vakcin\u0101cija stingri rekomend\u0113jama im\u016bnsupres\u0113tiem cilv\u0113kiem un vi\u0146u cie\u0161\u0101m kontaktperson\u0101m, cilv\u0113kiem ar hronisk\u0101m slim\u012bb\u0101m, ilgsto\u0161iem soci\u0101l\u0101s apr\u016bpes centru iem\u012btniekiem un vi\u0146u apr\u016bpes person\u0101lam, senioriem vecum\u0101 no 65 gadiem, vesel\u012bbas apr\u016bpes person\u0101lam un gr\u016btniec\u0113m. Tai skait\u0101 saska\u0146\u0101 ar IVP rekomend\u0101ciju ar piel\u0101goto vakc\u012bnu var veikt ar\u012b prim\u0101ro vakcin\u0101ciju. Pla\u0161\u0101ka inform\u0101cija ir pieejama <\/strong>S<\/strong>lim\u012bbu profilakses un kontroles centra (SPKC)<\/strong> t\u012bmek\u013cvietn\u0113<\/strong><\/a>.<\/strong><\/p>\n\n\n\n Kad piel\u0101got\u0101s vakc\u012bnas b\u016bs pieejamas Latvij\u0101?<\/strong><\/p>\n\n\n\n EZA rekomend\u0101cija ir nos\u016bt\u012bta Eiropas Komisijai, kas tuv\u0101kaj\u0101 laik\u0101 pie\u0146ems vis\u0101m Eiropas Savien\u012bbas (ES)dal\u012bbvalst\u012bm juridiski saisto\u0161u gala l\u0113muma par piel\u0101goto vakc\u012bnu re\u0123istr\u0101ciju. P\u0113c Eiropas Komisijas gala l\u0113muma piel\u0101got\u0101s vakc\u012bnas b\u016bs apstiprin\u0101tas lieto\u0161anai vis\u0101 ES, tostarp ar\u012b Latvij\u0101.<\/p>\n\n\n\n Atbilsto\u0161i Nacion\u0101lajam vesel\u012bbas dienestam (NVD)pieejamajai inform\u0101cijai, paredzams, ka pirm\u0101 piel\u0101goto vakc\u012bnu pret Covid-19 kravas pieg\u0101de Latvij\u0101 var\u0113tu b\u016bt ned\u0113\u013cas laik\u0101 p\u0113c vakc\u012bnu re\u0123istr\u0113\u0161anas EZA \u2013 provizoriski n\u0101kam\u0101s ned\u0113\u013cas vid\u016b. \u0122imenes \u0101rstu prakses un vakcin\u0101cijas kabineti p\u0113c piel\u0101goto vakc\u012bnu pieg\u0101d\u0101\u0161anas uz Latviju var\u0113s t\u0101s pas\u016bt\u012bt un izmantot iedz\u012bvot\u0101ju vakcin\u0113\u0161anai.<\/p>\n\n\n\n K\u0101 pieteikties vakcin\u0101cijai pret Covid-19<\/strong> ar piel\u0101gotaj\u0101m vakc\u012bn\u0101m?<\/strong><\/p>\n\n\n\n T\u0101pat k\u0101 \u0161obr\u012bd ar\u012b p\u0113c piel\u0101goto Covid-19 vakc\u012bnu pieg\u0101des, lai pieteiktos vakcin\u0101cijai, aicin\u0101m sazin\u0101ties ar sava \u0123imenes \u0101rsta praksi vai \u0101rstniec\u012bbas iest\u0101des vakcin\u0101cijas kabinetu. Vakcin\u0101cijai var pieteikties ar\u012b t\u012bmek\u013ca vietn\u0113 Manavakcina.lv. <\/p>\n\n\n\n Tikl\u012bdz <\/strong>piel\u0101got\u0101s <\/strong>vakc\u012bnas tiks pieg\u0101d\u0101tas, <\/strong>SPKC un NVD<\/strong> sniegs <\/strong>pla\u0161\u0101ku<\/strong> inform\u0101ciju<\/strong>.<\/strong><\/p>\n","protected":false},"excerpt":{"rendered":" Z\u0101\u013cu valsts a\u0123ent\u016bra inform\u0113, ka Eiropas Z\u0101\u013cu a\u0123ent\u016bras (EZA) Z\u0101\u013cu re\u0123istr\u0101cijas komiteja (CHMP) ir ieteikusi re\u0123istr\u0113t divas vakc\u012bnas, kas ir piel\u0101gotas, lai nodro\u0161in\u0101tu pla\u0161\u0101ku aizsardz\u012bbu pret Covid-19. Piel\u0101got\u0101s vakc\u012bnas \u201cComirnaty Original\/Omicron BA.1\u201d un \u201cSpikevax Bivalent Original\/Omicron BA.1\u201d ir paredz\u0113tas lieto\u0161anai person\u0101m no 12 gadu vecuma, kuras sa\u0146\u0113mu\u0161as vismaz prim\u0101ro vakcin\u0101ciju pret Covid-19. \u0160\u012bs piel\u0101got\u0101s vakc\u012bnas ir ori\u0123in\u0101lo vakc\u012bnu \u201cComirnaty\u201d (Pfizer\/BioNTech) un […]<\/p>\n","protected":false},"author":2,"featured_media":9946,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_jetpack_memberships_contains_paid_content":false,"jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":false,"jetpack_social_options":{"image_generator_settings":{"template":"highway","enabled":false}}},"categories":[38],"tags":[],"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/i0.wp.com\/inews24.eu\/wp-content\/uploads\/2022\/09\/66954A37-AB85-4391-BF38-4F9067BB33FF.jpeg?fit=1024%2C732&ssl=1","jetpack_sharing_enabled":true,"jetpack-related-posts":[],"_links":{"self":[{"href":"https:\/\/inews24.eu\/wp-json\/wp\/v2\/posts\/9945"}],"collection":[{"href":"https:\/\/inews24.eu\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/inews24.eu\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/inews24.eu\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/inews24.eu\/wp-json\/wp\/v2\/comments?post=9945"}],"version-history":[{"count":0,"href":"https:\/\/inews24.eu\/wp-json\/wp\/v2\/posts\/9945\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/inews24.eu\/wp-json\/wp\/v2\/media\/9946"}],"wp:attachment":[{"href":"https:\/\/inews24.eu\/wp-json\/wp\/v2\/media?parent=9945"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/inews24.eu\/wp-json\/wp\/v2\/categories?post=9945"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/inews24.eu\/wp-json\/wp\/v2\/tags?post=9945"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}